A citation-based method for searching scientific literature

Massimo Volpe, Speranza Rubattu, John Burnett. Eur Heart J 2014
Times Cited: 166







List of co-cited articles
707 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
33

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
19

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.
Marica Bordicchia, Dianxin Liu, Ez-Zoubir Amri, Gerard Ailhaud, Paolo Dessì-Fulgheri, Chaoying Zhang, Nobuyuki Takahashi, Riccardo Sarzani, Sheila Collins. J Clin Invest 2012
596
13

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
13

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Milton Packer, John J V McMurray, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. Circulation 2015
423
12


Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Lincoln R Potter, Andrea R Yoder, Darcy R Flora, Laura K Antos, Deborah M Dickey. Handb Exp Pharmacol 2009
329
12

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
9

Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
Speranza Rubattu, Sebastiano Sciarretta, Valentina Valenti, Rosita Stanzione, Massimo Volpe. Am J Hypertens 2008
144
9

A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.
Valentina Cannone, Guido Boerrigter, Alessandro Cataliotti, Lisa C Costello-Boerrigter, Timothy M Olson, Paul M McKie, Denise M Heublein, Brian D Lahr, Kent R Bailey, Maurizio Averna,[...]. J Am Coll Cardiol 2011
75
12

Cardiac fibrosis in mice lacking brain natriuretic peptide.
N Tamura, Y Ogawa, H Chusho, K Nakamura, K Nakao, M Suda, M Kasahara, R Hashimoto, G Katsuura, M Mukoyama,[...]. Proc Natl Acad Sci U S A 2000
439
9

Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.
S W John, J H Krege, P M Oliver, J R Hagaman, J B Hodgin, S C Pang, T G Flynn, O Smithies. Science 1995
497
9

Molecular Implications of Natriuretic Peptides in the Protection from Hypertension and Target Organ Damage Development.
Speranza Rubattu, Maurizio Forte, Simona Marchitti, Massimo Volpe. Int J Mol Sci 2019
25
36


Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Milton Packer, Robert M Califf, Marvin A Konstam, Henry Krum, John J McMurray, Jean-Lucien Rouleau, Karl Swedberg. Circulation 2002
470
8



Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.
P M Oliver, J E Fox, R Kim, H A Rockman, H S Kim, R L Reddick, K N Pandey, S L Milgram, O Smithies, N Maeda. Proc Natl Acad Sci U S A 1997
463
8

Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.
Christopher Newton-Cheh, Martin G Larson, Ramachandran S Vasan, Daniel Levy, Kenneth D Bloch, Aarti Surti, Candace Guiducci, Sekar Kathiresan, Emelia J Benjamin, Joachim Struck,[...]. Nat Genet 2009
308
8


Effect of nesiritide in patients with acute decompensated heart failure.
C M O'Connor, R C Starling, A F Hernandez, P W Armstrong, K Dickstein, V Hasselblad, G M Heizer, M Komajda, B M Massie, J J V McMurray,[...]. N Engl J Med 2011
848
7

Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
Thomas J Wang, Martin G Larson, Daniel Levy, Emelia J Benjamin, Eric P Leip, Torbjorn Omland, Philip A Wolf, Ramachandran S Vasan. N Engl J Med 2004
7

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
N Matsukawa, W J Grzesik, N Takahashi, K N Pandey, S Pang, M Yamauchi, O Smithies. Proc Natl Acad Sci U S A 1999
318
7

A new natriuretic peptide in porcine brain.
T Sudoh, K Kangawa, N Minamino, H Matsuo. Nature 1988
7

Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide.
M J Lopez, S K Wong, I Kishimoto, S Dubois, V Mach, J Friesen, D L Garbers, A Beuve. Nature 1995
393
7

Impact of obesity on plasma natriuretic peptide levels.
Thomas J Wang, Martin G Larson, Daniel Levy, Emelia J Benjamin, Eric P Leip, Peter W F Wilson, Ramachandran S Vasan. Circulation 2004
699
7

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. Circulation 2017
7

Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
Eric J Velazquez, David A Morrow, Adam D DeVore, Carol I Duffy, Andrew P Ambrosy, Kevin McCague, Ricardo Rocha, Eugene Braunwald. N Engl J Med 2019
452
7

Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.
Fima Macheret, Denise Heublein, Lisa C Costello-Boerrigter, Guido Boerrigter, Paul McKie, Diego Bellavia, Sarah Mangiafico, Yasuhiro Ikeda, Kent Bailey, Christopher G Scott,[...]. J Am Coll Cardiol 2012
68
10

The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.
Massimo Volpe, Marino Carnovali, Vittoria Mastromarino. Clin Sci (Lond) 2016
132
6

Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.
Camilla Calvieri, Speranza Rubattu, Massimo Volpe. J Mol Med (Berl) 2012
45
13

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
W S Colucci, U Elkayam, D P Horton, W T Abraham, R C Bourge, A D Johnson, L E Wagoner, M M Givertz, C S Liang, M Neibaur,[...]. N Engl J Med 2000
698
6

Natriuretic peptides in cardiometabolic regulation and disease.
Nora E Zois, Emil D Bartels, Ingrid Hunter, Birgitte S Kousholt, Lisbeth H Olsen, Jens P Goetze. Nat Rev Cardiol 2014
110
6

Innovative Therapeutics: Designer Natriuretic Peptides.
Laura M G Meems, John C Burnett. JACC Basic Transl Sci 2016
31
19

Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
Rita Holtwick, Martin van Eickels, Boris V Skryabin, Hideo A Baba, Alexander Bubikat, Frank Begrow, Michael D Schneider, David L Garbers, Michaela Kuhn. J Clin Invest 2003
281
6

Natriuretic peptides and cardio-renal disease.
Massimo Volpe. Int J Cardiol 2014
72
8

Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes.
M E Steinhelper, K L Cochrane, L J Field. Hypertension 1990
232
6

Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.
Speranza Rubattu, Giada Bigatti, Anna Evangelista, Chiara Lanzani, Rosita Stanzione, Laura Zagato, Paolo Manunta, Simona Marchitti, Vanessa Venturelli, Giuseppe Bianchi,[...]. J Am Coll Cardiol 2006
110
6

Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.
Stefan Engeli, Andreas L Birkenfeld, Pierre-Marie Badin, Virginie Bourlier, Katie Louche, Nathalie Viguerie, Claire Thalamas, Emilie Montastier, Dominique Larrouy, Isabelle Harant,[...]. J Clin Invest 2012
125
6

A Test in Context: Neprilysin: Function, Inhibition, and Biomarker.
Antoni Bayes-Genis, Jaume Barallat, A Mark Richards. J Am Coll Cardiol 2016
133
6

Effects of dual angiotensin type 1 receptor/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat.
Speranza Rubattu, Maria Cotugno, Maurizio Forte, Rosita Stanzione, Franca Bianchi, Michele Madonna, Simona Marchitti, Massimo Volpe. J Hypertens 2018
13
46

Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study.
Kazuomi Kario, Ningling Sun, Fu-Tien Chiang, Ouppatham Supasyndh, Sang Hong Baek, Akiko Inubushi-Molessa, Ying Zhang, Hiromi Gotou, Martin Lefkowitz, Jack Zhang. Hypertension 2014
142
6

Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study.
Bryan Williams, John R Cockcroft, Kazuomi Kario, Dion H Zappe, Patrick C Brunel, Qian Wang, Weinong Guo. Hypertension 2017
104
6

Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive Hypertension.
Tzung-Dau Wang, Ru-San Tan, Hae-Young Lee, Sang-Hyun Ihm, Moo-Yong Rhee, Brian Tomlinson, Parasar Pal, Fan Yang, Elizabeth Hirschhorn, Margaret F Prescott,[...]. Hypertension 2017
61
9

Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.
Nasrien E Ibrahim, Cian P McCarthy, Shreya Shrestha, Hanna K Gaggin, Renata Mukai, Jackie Szymonifka, Fred S Apple, John C Burnett, Seethalakshmi Iyer, James L Januzzi. J Am Coll Cardiol 2019
63
9


Atrial and brain natriuretic peptides: Hormones secreted from the heart.
Yasuaki Nakagawa, Toshio Nishikimi, Koichiro Kuwahara. Peptides 2019
59
10

Cardiac natriuretic peptides.
Jens P Goetze, Benoit G Bruneau, Hugo R Ramos, Tsuneo Ogawa, Mercedes Kuroski de Bold, Adolfo J de Bold. Nat Rev Cardiol 2020
93
6

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
R J Cody, S A Atlas, J H Laragh, S H Kubo, A B Covit, K S Ryman, A Shaknovich, K Pondolfino, M Clark, M J Camargo. J Clin Invest 1986
774
5

Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events.
Risto Kerkelä, Johanna Ulvila, Johanna Magga. J Am Heart Assoc 2015
75
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.